1. Home
  2. NWL vs URGN Comparison

NWL vs URGN Comparison

Compare NWL & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

HOLD

Current Price

$6.17

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$38.98

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWL
URGN
Founded
1903
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
NWL
URGN
Price
$6.17
$38.98
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$4.97
$29.29
AVG Volume (30 Days)
10.5M
717.0K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$14,742,200,000.00
$1,128,000.00
Revenue This Year
$1.19
$129.09
Revenue Next Year
$1.58
$70.96
P/E Ratio
$37.41
N/A
Revenue Growth
11.14
N/A
52 Week Low
$3.07
$15.86
52 Week High
$7.13
$43.93

Technical Indicators

Market Signals
Indicator
NWL
URGN
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NWL
URGN

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: